Jennifer G. Walker

A Treat-to-Target Strategy Preserves Work Capacity in a Rheumatoid Arthritis Inception Cohort Treated With Combination Conventional DMARD Therapy

C. Hill, Malcolm D. Smith, E. Shanahan, 2017, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

The development of systemic sclerosis classification criteria

M. Hudson, S. Taillefer, M. Baron, 2007, Clinical Rheumatology.

Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects

M. Mayes, M. Hudson, M. Baron, 2015, Autoimmunity.

Hypocomplementemia in systemic sclerosis--clinical and serological correlations.

M. Hudson, S. Taillefer, M. Baron, 2007, The Journal of rheumatology.

The association of low complement with disease activity in systemic sclerosis: a prospective cohort study

J. Esposito, S. Proudman, M. Nikpour, 2016, Arthritis Research & Therapy.

Stochastic processes in the causation of rheumatic disease.

Malcolm D. Smith, M. Ahern, P. Roberts-Thomson, 2002, The Journal of rheumatology.

Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic Sclerosis

Rosa M. Estrada-Y.-Martin, M. Mayes, M. Hudson, 2017, The Journal of Rheumatology.